account_balance
Investment manager · 13F filer · SEC CIK 1744967
Samsara Biocapital, LLC
Reported value$1.22Bas of Jun 30, 2026
Positions24 4 new, 2 sold out
Top 10 weight90.5%SRRK alone is 31%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
SRRKScholar Rock HLDG Corp
31.2%
ALMSAlumis Inc
14.7%
MLYSMineralys Therapeutics Inc
13.0%
SEPNSepterna Inc
8.7%
ALMRAlamar Biosciences Inc
5.5%New
NGNENeurogene Inc
4.4%
KLRSKalaris Therapeutics Inc
4.3%
SGPSpyglass Pharma Inc
3.9%
STROSutro Biopharma Inc
2.9%
IVA2.0%JBIOJade Biosciences Inc
1.3%Trimmed −24%
PBLS1.3%SRRKScholar Rock HLDG Corp
31.2%
ALMS14.7%MLYSMineralys Therapeutics Inc
13.0%
SEPNSepterna Inc
8.7%
ALMR5.5%NGNE4.4%KLRS4.3%SGP3.9%STRO2.9%IVA2.0%JBIOBoxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
SRRK Scholar Rock HLDG Corp 31.2% HeldALMS Alumis Inc 14.7% HeldMLYS Mineralys Therapeutics Inc 13.0% HeldSEPN Septerna Inc 8.7% HeldALMR Alamar Biosciences Inc 5.5% NewNGNE Neurogene Inc 4.4% HeldKLRS Kalaris Therapeutics Inc 4.3% HeldSGP Spyglass Pharma Inc 3.9% HeldSTRO Sutro Biopharma Inc 2.9% HeldIVA Inventiva SA 2.0% Added +22%JBIO Jade Biosciences Inc 1.3% Trimmed −24%PBLS Parabilis Medicines Inc 1.3% New
What changed